INS and polycystic ovary syndrome: Therefore, GLP-1R agonists, such as liraglutide and dulaglutide, have shown therapeutic potential in PCOS by reducing hyperandrogenemia, improving insulin sensitivity, and promoting weight loss [222,223,224,225,226,227,228,229].